Liberum appointed Joint Corporate Broker to MedicX Fund Limited
Liberum is pleased to announce its appointment as Joint Corporate Broker to MedicX Fund Limited.
MedicX is a specialist primary healthcare REIT which invests in modern, purpose-built primary healthcare properties in the UK & Republic of Ireland. The Company has a portfolio of 151 completed properties with an average value of £4.4m.
MedicX selectively buys high quality dominant assets or forward-funds new schemes under framework agreements with a range of experienced developers in both the UK and the Republic of Ireland.
The fund is listed on the Premium Segment of the Main Market and has a market capitalisation of c.£346m.
Liberum has been appointed as Joint Corporate Broker alongside Canaccord, with immediate effect.
Board – David Parsons
Investment Banking – Richard Crawley, Jamie Richards, Laura Hamilton, William Hall
Sales – John Mozley
Research – David Brockton
Corporate Access – Lucy Williams
Press Enquiries: Redleaf Polhill
Call: +44 (0)20 7382 4747